FeesSafety
Pluang+

Natural Gas Services Group to release Q3 2026 earnings on Nov 9, with conference call on Nov 10

Company Fundamentals
26 Oct 2026, 23:05 WIB
GlobeNewsWire
View Source
Neutral
Natural Gas Services Group to release Q3 2026 earnings on Nov 9, with conference call on Nov 10

Natural Gas Services Group, Inc. announced it will release its third-quarter 2026 financial results on November 9, 2026, after market close. The company will host a conference call to discuss these results on November 10, 2026, at 8:30 a.m. ET. Investors can access the call via the company’s website or by phone, with a replay available afterward. This update is important for stakeholders to assess the company’s recent performance in the natural gas compression equipment sector.

The third-quarter 2026 earnings release and conference call for Natural Gas Services Group, Inc. provide context for energy sector activity. For readers following the Energy sector, here is Pluang's market snapshot as of Oct 27, 2026 03:11 WIB: out of 79 priced US Energy stocks, 51 rose and 27 fell. Notably, Delek US Holdings Inc. (DK) increased 4.78% to USD 77.97 with a typical hold time of 12 days, while Diamondback Energy Inc. (FANG) rose 4.42% to USD 205.85 despite 98% sell order activity and a longer hold time of 70 days. In contrast, Indonesia Energy Corporation Limited (INDO) dropped 4.40% to USD 2.61 but saw 100% buy orders and a 26-day hold time.

More News

Exodus Movement to announce Q3 2026 financial results on Nov 9 with a webcast.

Exodus Movement to announce Q3 2026 financial results on Nov 9 with a webcast.

Exodus Movement, a self-custodial finance and payments platform, will release its third quarter 2026 financial results after market close on November 9, 2026. The company will host a webcast at 5:00 PM ET the same day to discuss the results. Founded ...

Company Fundamentals
Neutral
1 hour ago
Onco360 named national pharmacy partner for AstraZeneca's lung cancer drug Zegfrovy.

Onco360 named national pharmacy partner for AstraZeneca's lung cancer drug Zegfrovy.

Onco360, a leading independent specialty pharmacy, has been selected by AstraZeneca as a national pharmacy partner for Zegfrovy (sunvozertinib), a treatment for advanced non-small cell lung cancer with EGFR exon 20 insertion mutations. Zegfrovy has s...

Market News
Bullish
1 hour ago
S4A IT Solutions joins SAP PartnerEdge program, boosting its SAP consulting capabilities.

S4A IT Solutions joins SAP PartnerEdge program, boosting its SAP consulting capabilities.

S4A IT Solutions has been accepted into the SAP PartnerEdge program, marking a key milestone in its growth. This partnership enhances S4A's ability to help organizations maximize their SAP investments, especially in areas like asset management and su...

Market News
Bullish
2 hours ago
SEC policy shifts and rising shareholder activism shape 2027 proxy season preparations for public companies

SEC policy shifts and rising shareholder activism shape 2027 proxy season preparations for public companies

Public companies are facing new challenges for the 2027 proxy season due to changes in SEC policies, evolving shareholder activism strategies, and shifts in institutional investor voting. A virtual roundtable on October 28 will gather experts to disc...

Market News
Neutral
3 hours ago
Gogo to release Q3 2026 earnings on Nov 6 with a conference call for analysts.

Gogo to release Q3 2026 earnings on Nov 6 with a conference call for analysts.

Gogo Inc., a leading provider of in-flight broadband connectivity, announced it will report its third quarter 2026 financial results on November 6, 2026, before the market opens. The company will hold a conference call with financial analysts the sam...

Company Fundamentals
Neutral
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App